Skip to main content
. 2022 Mar 31;89(7):1938–1947. doi: 10.1111/bcp.15318

FIGURE 2.

FIGURE 2

Comparison of combined buprenorphine urine (A) or plasma (B) concentrations at all time points (n = 80) vs qualitative urine drug screen results (n = 79). Detection of buprenorphine on qualitative UDS was associated with higher urine and plasma concentrations in quantitative testing (P < .0001, P = .0021, respectively). Solid lines represent the median. Error bars represent range